Kondás J, Szentgyörgyi E
Department of Urology, Municipal Péterfy Sándor Street Hospital, Budapest, Hungary.
Int Urol Nephrol. 1992;24(1):35-42. doi: 10.1007/BF02552115.
A total of 1250 bladder tumours were subjected to transurethral resection (891 curative, 107 palliative operations, 252 TUR biopsies). Complication rate was 9.9%, mortality rate 0.8%. In patients with primary tumours the 1-year recurrence rate after TUR was 23.8%, the 3-year rate was 36.6%, with an increase in proportion to stage. The 5-year survival rate was 66.5%. Within five years 9% of the patients died from tumour generalization, also with a rising tendency in proportion to stage. TUR as a curative method is suitable mainly for the removal of Ta and T1, under circumstances also of T2 G1-G2 tumours.
共有1250例膀胱肿瘤接受了经尿道切除术（891例根治性手术，107例姑息性手术，252例经尿道切除术活检）。并发症发生率为9.9%，死亡率为0.8%。原发性肿瘤患者经尿道切除术后1年复发率为23.8%，3年复发率为36.6%，且复发率随分期增加而升高。5年生存率为66.5%。五年内9%的患者死于肿瘤转移，转移率也随分期增加而呈上升趋势。经尿道切除术作为一种根治性方法主要适用于Ta期和T1期肿瘤的切除，在某些情况下也适用于T2 G1-G2期肿瘤。
